Profile data is unavailable for this security.
About the company
DuPont de Nemours, Inc. provides technology-based materials and solutions. The Company’s segments include Electronics & Industrial and Water & Protection. The Electronics & Industrial segment is a provider of differentiated materials and component solutions for computing, 5G, electric vehicles (EV), a range of consumer electronics, including mobile devices, television monitors, personal computers and a variety of other industries including aerospace, defense, transportation, healthcare, and medical devices. The segment supplies materials and solutions for the fabrication of semiconductors and integrated circuits addressing multiple steps of the manufacturing process. The Water & Protection segment provides engineered products and integrated systems for a number of industries including, worker safety, water purification and separation, transportation, energy, medical packaging and building materials. Its brands include NOMEX, KEVLAR, TYVEK, FILMTEC, AMBERLITE, and STYROFOAM.
- Revenue in USD (TTM)11.98bn
- Net income in USD404.00m
- Incorporated2015
- Employees24.00k
- LocationDupont De Nemours Inc974 Centre Rd Bldg 730WILMINGTON 19805United StatesUSA
- Phone+1 (302) 295-5783
- Fax+1 (302) 655-5049
- Websitehttps://www.dupont.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. | 2.00bn | -332.08m | 18.78bn | 2.10k | -- | -- | -- | 9.37 | -2.71 | -2.71 | 15.78 | -1.73 | 0.5552 | 2.85 | 11.67 | 953,969.10 | -9.20 | -26.56 | -11.86 | -32.77 | 83.95 | 83.66 | -16.58 | -94.26 | 3.07 | -1.37 | 1.27 | -- | 76.23 | 89.45 | 61.08 | -- | -13.29 | -- |
| ICON PLC | 8.23bn | 683.12m | 26.86bn | 41.10k | 39.41 | 2.85 | 21.10 | 3.26 | 8.24 | 8.24 | 99.33 | 114.08 | 0.4795 | -- | 2.92 | 200,291.60 | 3.98 | 3.93 | 4.80 | 4.80 | 29.67 | 28.91 | 8.30 | 7.37 | -- | 3.48 | 0.2706 | -- | 4.89 | 25.62 | 21.18 | 13.67 | 23.79 | -- |
| Gartner Inc | 5.97bn | 797.23m | 32.58bn | 20.29k | 41.77 | 45.70 | 32.87 | 5.46 | 10.05 | 10.05 | 75.24 | 9.18 | 0.7915 | -- | 3.80 | 295,054.30 | 10.57 | 8.24 | 19.95 | 14.76 | 67.72 | 67.55 | 13.35 | 12.20 | -- | 13.10 | 0.7738 | -- | 7.87 | 8.24 | 9.24 | 49.78 | -4.06 | -- |
| Biogen Inc | 9.66bn | 1.17bn | 32.75bn | 7.57k | 28.11 | 2.15 | 19.29 | 3.39 | 8.00 | 8.00 | 66.40 | 104.48 | 0.3777 | 1.27 | 4.80 | 1,276,499.00 | 4.56 | 12.53 | 5.20 | 14.83 | 75.03 | 81.84 | 12.08 | 26.93 | 1.32 | 3.78 | 0.3007 | 0.00 | -3.32 | -6.07 | -61.89 | -23.58 | -18.87 | -- |
| DuPont de Nemours Inc | 11.98bn | 404.00m | 34.35bn | 24.00k | 94.05 | 1.46 | 21.42 | 2.87 | 0.8736 | 0.8126 | 27.12 | 56.41 | 0.3036 | 3.37 | 4.99 | 499,208.30 | 1.12 | 0.3709 | 1.24 | 0.468 | 35.15 | 35.69 | 3.70 | 1.97 | 1.61 | 6.24 | 0.2446 | 414.03 | -7.29 | -11.79 | -51.19 | 11.24 | -30.66 | -20.59 |
| Iqvia Holdings Inc | 15.07bn | 1.36bn | 39.92bn | 87.00k | 29.89 | 6.29 | 16.01 | 2.65 | 7.33 | 7.33 | 81.34 | 34.82 | 0.5761 | -- | 4.64 | 173,206.90 | 5.19 | 3.24 | 6.93 | 4.07 | 35.03 | 34.32 | 9.01 | 6.03 | -- | 3.19 | 0.6809 | 0.00 | 3.98 | 7.55 | 24.47 | 43.39 | 7.17 | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 44.78m | 10.72% |
| Massachusetts Financial Services Co.as of 31 Mar 2024 | 21.73m | 5.20% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 20.67m | 4.95% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 16.94m | 4.06% |
| Geode Capital Management LLCas of 31 Mar 2024 | 9.88m | 2.37% |
| Invesco Advisers, Inc.as of 31 Mar 2024 | 7.38m | 1.77% |
| Putnam Investment Management LLCas of 31 Mar 2024 | 5.26m | 1.26% |
| Macquarie Investment Management Business Trustas of 31 Mar 2024 | 4.86m | 1.16% |
| TIAA-CREF Investment Management LLCas of 31 Mar 2024 | 4.81m | 1.15% |
| Barrow, Hanley, Mewhinney & Strauss LLCas of 31 Mar 2024 | 4.43m | 1.06% |
